Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and efficacy of lefamulin, a pleuromutilin, for the treatment
of adults with moderate community-acquired bacterial pneumonia
Phase:
Phase 3
Details
Lead Sponsor:
Nabriva Therapeutics AG
Treatments:
Anti-Bacterial Agents Fluoroquinolones Lefamulin Moxifloxacin Norgestimate, ethinyl estradiol drug combination